The rise of Viagra initially sparked a surge for pharma, nevertheless recent changes present a uncertain outlook for shareholders. Off-patent versions are reducing profits, and ongoing legal battles add additional risk https://rsadyvv282969.fare-blog.com/41587564/sildenafil-and-big-pharma-a-volatile-bet